Chapter 25: Peptide Drug/Device Combinations

2020 ◽  
pp. 613-637
Author(s):  
Shahid Uddin
Keyword(s):  
Peptide Drug

Unique Functional Materials Derived from β-Amino Acid Oligomers

2017 ◽  
Vol 70 (2) ◽  
pp. 126 ◽  
Author(s):  
Mark P. Del Borgo ◽  
Ketav Kulkarni ◽  
Marie-Isabel Aguilar
Keyword(s):  
Amino Acid ◽  
Drug Design ◽  
Self Assembly ◽  
Functional Materials ◽  
Bioactive Molecules ◽  
Peptide Drug ◽  
New Materials ◽  
Amino Acid Oligomers

The unique structures formed by β-amino acid oligomers, or β-peptide foldamers, have been studied for almost two decades, which has led to the discovery of several distinctive structures and bioactive molecules. Recently, this area of research has expanded from conventional peptide drug design to the formation of assemblies and nanomaterials by peptide self-assembly. The unique structures formed by β-peptides give rise to a set of new materials with altered properties that differ from conventional peptide-based materials; such new materials may be useful in several bio- and nanomaterial applications.

A simple supramolecular assay for drug detection in urine

2017 ◽  
Vol 53 (63) ◽  
pp. 8842-8845 ◽  
Author(s):  
Silvia Sonzini ◽  
Jade A. McCune ◽  
Peter Ravn ◽  
Oren A. Scherman ◽  
Christopher F. van der Walle
Keyword(s):  
Colorimetric Assay ◽  
Neutral Red ◽  
Peptide Drug ◽  
Drug Detection ◽  
Therapeutic Peptide ◽  
Novel Method ◽  
Dye Molecule

A supramolecular colorimetric assay utilising the macrocyclic host cucurbit[7]uril with a commercial dye molecule, neutral red, was evaluated as a novel method for drug detection in urine of a model therapeutic peptide drug Octreotide.

Peptide drug delivery to the brain

1993 ◽  
Vol 86 (2) ◽  
pp. 143
Author(s):  
Daniel F. Hanley
Keyword(s):  
Drug Delivery ◽  
Peptide Drug ◽  
The Brain

Properties of HIV envelope expressed in the presence of SPC3, an Env-derived peptide drug under phase II clinical trials

2009 ◽  
Vol 52 (4) ◽  
pp. 283-288 ◽  
Author(s):  
R. Barbouche ◽  
E. Fenouillet ◽  
M.-J. Papandréou ◽  
M.P. Kiény ◽  
J M. Sabatier
Keyword(s):  
Clinical Trials ◽  
Phase Ii ◽  
Peptide Drug ◽  
Phase Ii Clinical Trials ◽  
Hiv Envelope

Source and exploration of the peptides used to construct peptide-drug conjugates

2021 ◽  
pp. 113712
Author(s):  
Jiaqi Zhou ◽  
Yuanyuan Li ◽  
Wenlong Huang ◽  
Wei Shi ◽  
Hai Qian
Keyword(s):  
Peptide Drug ◽  
Drug Conjugates ◽  
Peptide Drug Conjugates

Discovery of peptide drug carrier candidates for targeted multi-drug delivery into prostate cancer cells

2017 ◽  
Vol 408 ◽  
pp. 164-173 ◽  
Author(s):  
O. Bashari ◽  
B. Redko ◽  
A. Cohen ◽  
G. Luboshits ◽  
G. Gellerman ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Drug Delivery ◽  
Cancer Cells ◽  
Drug Carrier ◽  
Peptide Drug ◽  
Prostate Cancer Cells
Sign in / Sign up

Export Citation Format

Share Document